Pharmaceutical multinational corporations (MNCs) and their exit from low and middle income countries (LMICs): analysing the causes and consequences.

Khan MAA

Open source

DOI
10.1080/20523211.2024.2428992
Published
2024
Container
Journal of pharmaceutical policy and practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/20523211.2024.2428992,
  title = {Pharmaceutical multinational corporations (MNCs) and their exit from low and middle income countries (LMICs): analysing the causes and consequences.},
  author = {Khan MAA},
  year = {2024},
  journal = {Journal of pharmaceutical policy and practice},
  doi = {10.1080/20523211.2024.2428992},
  url = {https://doi.org/10.1080/20523211.2024.2428992}
}

RIS

TY  - JOUR
TI  - Pharmaceutical multinational corporations (MNCs) and their exit from low and middle income countries (LMICs): analysing the causes and consequences.
AU  - Khan MAA
PY  - 2024
JO  - Journal of pharmaceutical policy and practice
DO  - 10.1080/20523211.2024.2428992
UR  - https://doi.org/10.1080/20523211.2024.2428992
ER  - 

APA

MAA, K. (2024). Pharmaceutical multinational corporations (MNCs) and their exit from low and middle income countries (LMICs): analysing the causes and consequences.. Journal of pharmaceutical policy and practice. https://doi.org/10.1080/20523211.2024.2428992

Source records